Axsome Therapeutics AXSM
NASDAQ AXSM
$179.25 -2.82 (-1.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Axsome Therapeutics (AXSM) Change in Accured Expenses (2015 - 2026)

Updated

Axsome Therapeutics' Change in Accured Expenses was $46.61 million in Q2 2026, up 116.8% from $21.5 million a year earlier and up 170.5% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Change in Accured Expenses (2015 - 2026) Analysis & Trends

On a trailing twelve-month basis, Axsome Therapeutics' Change in Accured Expenses was $125.26 million through Jun 30, 2026, up 134.9% year-over-year; for FY2025, it was $83.74 million, up 49.4% from FY2024.

  • In earlier years, Change in Accured Expenses was $56.07 million in FY2024 (+53.8%), $36.45 million in FY2023 (-17.0%), $43.92 million in FY2022 and $582,000 in FY2021.
  • Quarterly Change in Accured Expenses has moved between -$8.42 million (Q1 2024) and $54.25 million (Q3 2025) over five years.
  • Compared with a year earlier, Change in Accured Expenses was higher in three of the last six quarters, with growth averaging 165.3%.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q3 2025 (growth of 919.1%); the worst was Q3 2021 (a decline of 85.4%).
  • Per Business Quant data, AXSM's Change in Accured Expenses in the three quarters before Q2 2026 was $17.23 million (Q1 2026), $7.17 million (Q4 2025) and $54.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Axsome Therapeutics 9.37 Bn 8.10 Bn 204.81 Mn 46.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.61 Mn
Mar 31, 2026 17.23 Mn
Dec 31, 2025 7.17 Mn
Sep 30, 2025 54.25 Mn
Jun 30, 2025 21.50 Mn
Mar 31, 2025 818,000.00
Dec 31, 2024 25.67 Mn
Sep 30, 2024 5.32 Mn
Jun 30, 2024 33.49 Mn
Mar 31, 2024 -8.42 Mn
Dec 31, 2023 11.36 Mn
Sep 30, 2023 13.99 Mn
Jun 30, 2023 3.96 Mn
Mar 31, 2023 7.14 Mn
Dec 31, 2022 13.20 Mn
Sep 30, 2022 23.54 Mn
Jun 30, 2022 5.49 Mn
Mar 31, 2022 1.69 Mn
Dec 31, 2021 -1.15 Mn
Sep 30, 2021 282,341.00
API Access

Axsome Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=AXSM&period=max&api_key=YOUR_API_KEY